Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
GONADOTROPHIN EQUINE SERUM (PMSG), GONADOTROPHIN CHORIONIC (HCG)
Ceva Santé Animale
QG03GA99
GONADOTROPHIN EQUINE SERUM (PMSG), GONADOTROPHIN CHORIONIC (HCG)
Unknown
Lyophilisate and solvent for solution for injection
POM
Porcine
Gonadotropins, combinations
Hormone
Authorised
2010-01-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Fertipig HCG 40 IU/ml / PMSG 80 IU/ml lyophilisate and solvent for solution for injection for pigs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Lyophilisate and solvent for solution for injection. Lyophilisate: white to off-white freeze-dried powder. Solvent: clear colourless solution. Reconstituted solution: clear colourless solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES To sows after weaning: Induction and synchronization of œstrus within 7 days following the treatment. Reduction of the weaning to oestrus interval in sows with late oestrus. Treatment of the seasonal anoestrus. Lyophilisate vial contains: ACTIVE SUBSTANCES Equine serum gonadotrophin (PMSG) 2 000 IU Gonadotrophin chorionic (HCG) 1 000 IU Solvent vial contains: EXCIPIENTS Benzyl alcohol (E1519) 375 mg One ml of reconstituted solution contains: ACTIVE SUBSTANCES Equine serum gonadotrophin (PMSG) 80 IU Gonadotrophin chorionic (HCG) 40 IU EXCIPIENTS Benzyl alcohol (E1519) Reconstituted solution for 1 dose of 5 ml contains: ACTIVE SUBSTANCES Equine serum gonadotrophin (PMSG) 400 IU Gonadotrophin chorionic (HCG) 200 IU EXCIPIENTS Benzyl alcohol (E1519) 75 mg For a full list of excipients, see section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 07/11/2014_ _CRN 7017641_ _page number: 1_ 4.3 CONTRAINDICATIONS Do not administer to pregnant animals. Do not administer to animals with known hypersensitivity to the active substances or to any of the excipients. Do not administer to sows with follicular cysts. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Treatment during the primary Read the complete document